Heat-induced recall of bleomycin skin changes.
D000505:Alopecia / Q000139:chemically induced*; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006358:Hot Temperature; D006801:Humans; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced*; D012871:Skin Diseases / Q000139:chemically induced*; D014067:Tonsillar Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D014750:Vincristine; D002945:Cisplatin